(-0.34%) 5 196.25 points
(-0.13%) 38 977 points
(-0.50%) 18 108 points
(-1.33%) $77.34
(2.90%) $2.27
(0.06%) $2 325.70
(0.22%) $27.61
(-0.84%) $980.10
(0.16%) $0.931
(0.36%) $10.94
(0.27%) $0.802
(0.65%) $92.03
Live Chart Being Loaded With Signals
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally...
Stats | |
---|---|
本日の出来高 | 217 789 |
平均出来高 | 258 103 |
時価総額 | 875.74B |
EPS | INR0 ( 2024-02-02 ) |
次の収益日 | ( INR0 ) 2024-05-28 |
Last Dividend | INR8.00 ( 2023-06-23 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 58.42 |
ATR14 | INR1.872 (0.07%) |
ボリューム 相関
Torrent Pharmaceuticals 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Torrent Pharmaceuticals 相関 - 通貨/商品
Torrent Pharmaceuticals 財務諸表
Annual | 2022 |
収益: | INR94.64B |
総利益: | INR67.29B (71.10 %) |
EPS: | INR36.79 |
FY | 2022 |
収益: | INR94.64B |
総利益: | INR67.29B (71.10 %) |
EPS: | INR36.79 |
FY | 2022 |
収益: | INR84.19B |
総利益: | INR58.81B (69.86 %) |
EPS: | INR22.97 |
FY | 2021 |
収益: | INR78.86B |
総利益: | INR56.51B (71.66 %) |
EPS: | INR36.99 |
Financial Reports:
No articles found.
Torrent Pharmaceuticals Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR14.00 (N/A) |
INR8.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.500 | 2003-06-10 |
Last Dividend | INR8.00 | 2023-06-23 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 32 | -- |
Total Paid Out | INR130.50 | -- |
Avg. Dividend % Per Year | 0.85% | -- |
Score | 2.4 | -- |
Div. Sustainability Score | 3.99 | |
Div.Growth Potential Score | 4.28 | |
Div. Directional Score | 4.14 | -- |
Year | Amount | Yield |
---|---|---|
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR7.00 | 1.01% |
2019 | INR8.50 | 0.96% |
2020 | INR7.50 | 0.81% |
2021 | INR17.50 | 1.25% |
2022 | INR20.00 | 1.23% |
2023 | INR22.00 | 1.42% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SYRMA.NS | No Dividend Player | 2023-09-01 | Insufficient data to determine frequency | 2 | 0.18% | |
NEWGEN.NS | Dividend Knight | 2023-06-20 | Annually | 7 | 2.26% | |
IFGLEXPOR.NS | Dividend Junior | 2023-08-17 | Annually | 21 | 1.57% | |
CHAMBLFERT.NS | Dividend Junior | 2023-08-21 | Annually | 23 | 1.58% | |
SAGCEM.NS | Dividend Junior | 2023-06-20 | Annually | 18 | 0.28% | |
LTIM.NS | Dividend Knight | 2023-07-10 | Semi-Annually | 9 | 0.87% | |
GHCL.NS | Dividend Junior | 2023-06-23 | Annually | 22 | 1.62% | |
ARVSMART.NS | No Dividend Player | 2023-07-21 | Sporadic | 6 | 0.13% | |
THOMASCOOK.NS | Dividend Junior | 2023-08-10 | Sporadic | 18 | 0.15% | |
ORIENTPPR.NS | Dividend Junior | 2023-08-01 | Annually | 18 | 1.07% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.146 | 1.500 | 7.09 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.233 | 1.500 | 8.52 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 6.33 | 1.000 | 8.77 | 8.77 | [3 - 30] |
operatingCashFlowPerShareTTM | 47.33 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 47.33 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.737 | 1.000 | 1.045 | 1.045 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.234 | 1.000 | 7.32 | 7.32 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.99 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 58.78 | 1.000 | 4.16 | 0 | [1 - 100] |
returnOnEquityTTM | 0.233 | 2.50 | 9.05 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 47.33 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.149 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 47.33 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -1.550 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.155 | 1.000 | 8.62 | 0 | [0.1 - 0.5] |
Total Score | 4.28 |
Torrent Pharmaceuticals
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。